Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1737 - 1744 of 11616 results
HHS, Treasury and Labor Issue More Guidance on the No Surprises Act
October 3, 2022| Blog| Viewpoint
US Needs To Double Grid Building Pace For Climate Change Law Benefits
October 2, 2022| News
Monthly TCPA Digest — September 2022
September 30, 2022| Article| Viewpoint
TCPA Litigation Update — Good News for Defendants Facing Claims Under Florida’s Mini-TCPA
September 30, 2022| Article| Viewpoint
Massachusetts Paid Family and Medical Leave Update – Contribution Rate Will Decrease Effective January 1, 2023
September 29, 2022| Blog| Viewpoint
FDA Is Accepting EUA Requests for Monkeypox Tests, But Time is of the Essence
September 28, 2022| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.